2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Acanthamoeba Keratitis: new trials by email Literature Review of Acanthamoeba Keratitis trials Research Report on Acanthamoeba Keratitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin - Acanthamoeba Keratitis, Fungal Keratitis | Phase 3 | Completed | University of California, San Francisco | 330 | 2022-08-03 | 2026-09-03 |
| Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis PHMB 0.08%, Propamidine 0.1%, placebo - Acanthamoeba Keratitis | Phase 3 | Completed | SIFI SpA | 135 | 2017-08-13 | 2023-08-22 |
Amebiasis (2) · Corneal Diseases (2) · Eye Diseases (2) · Eye Infections (2) · Eye Infections, Parasitic (2) · Infections (2) · Keratitis (2) · Parasitic Diseases (2) · Protozoan Infections (2)
Corneal Cross-Linking (1) · Natamycin (1) · Rose Bengal (1) · chlorhexidine gluconate (1) · dibrompropamidine (1) · polihexanide (1)
SIFI SpA (1) · University of California, San Francisco (1)
Brazil (1) · India (1) · Italy (1) · Poland (1) · United Kingdom (1)
Jennifer Rose-Nussbaumer, MD (1) · John Dart, MD (1) · Nicole Varnado, MPH (1) · Tom Lietman, MD (1)
PMID 37802392, PMID 39011096, PMID 39192339, PMID 41561665, PMID 42348235
UG1EY028518 (1)